Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 5
1996 4
1997 1
1998 4
1999 4
2000 3
2001 2
2002 8
2003 7
2004 11
2005 6
2006 11
2007 15
2008 7
2009 11
2010 6
2011 11
2012 7
2013 10
2014 22
2015 20
2016 9
2017 3
2018 2
2019 1
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

163 results
Results by year
Filters applied: . Clear all
Page 1
Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia.
Metzeler KH, Herold T, Rothenberg-Thurley M, Amler S, Sauerland MC, Görlich D, Schneider S, Konstandin NP, Dufour A, Bräundl K, Ksienzyk B, Zellmeier E, Hartmann L, Greif PA, Fiegl M, Subklewe M, Bohlander SK, Krug U, Faldum A, Berdel WE, Wörmann B, Büchner T, Hiddemann W, Braess J, Spiekermann K; AMLCG Study Group. Metzeler KH, et al. Among authors: fiegl m. Blood. 2016 Aug 4;128(5):686-98. doi: 10.1182/blood-2016-01-693879. Epub 2016 Jun 10. Blood. 2016. PMID: 27288520 Clinical Trial.
Reply.
Kocher F, Lunger F, Seeber A, Amann A, Pircher A, Hilbe W, Fiegl M. Kocher F, et al. Among authors: fiegl m. Clin Lung Cancer. 2016 Sep;17(5):e187. doi: 10.1016/j.cllc.2016.04.008. Epub 2016 May 7. Clin Lung Cancer. 2016. PMID: 27245293 No abstract available.
Blockade of the PD-1/PD-L1 axis augments lysis of AML cells by the CD33/CD3 BiTE antibody construct AMG 330: reversing a T-cell-induced immune escape mechanism.
Krupka C, Kufer P, Kischel R, Zugmaier G, Lichtenegger FS, Köhnke T, Vick B, Jeremias I, Metzeler KH, Altmann T, Schneider S, Fiegl M, Spiekermann K, Bauerle PA, Hiddemann W, Riethmüller G, Subklewe M. Krupka C, et al. Among authors: fiegl m. Leukemia. 2016 Feb;30(2):484-91. doi: 10.1038/leu.2015.214. Epub 2015 Aug 4. Leukemia. 2016. PMID: 26239198 Free article.
Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction.
Samudio I, Harmancey R, Fiegl M, Kantarjian H, Konopleva M, Korchin B, Kaluarachchi K, Bornmann W, Duvvuri S, Taegtmeyer H, Andreeff M. Samudio I, et al. Among authors: fiegl m. J Clin Invest. 2010 Jan;120(1):142-56. doi: 10.1172/JCI38942. Epub 2009 Dec 21. J Clin Invest. 2010. PMID: 20038799 Free PMC article.
Diagnostic and prognostic impact of mucin 1-6 expression in non-small cell lung cancer.
Sterlacci W, Fiegl M, Veits L, Tzankov A. Sterlacci W, et al. Among authors: fiegl m. Indian J Pathol Microbiol. 2018 Apr-Jun;61(2):187-191. doi: 10.4103/IJPM.IJPM_678_17. Indian J Pathol Microbiol. 2018. PMID: 29676354 Free article.
Microenvironmental oxygen partial pressure in acute myeloid leukemia: Is there really a role for hypoxia?
Rieger CT, Fiegl M. Rieger CT, et al. Among authors: fiegl m. Exp Hematol. 2016 Jul;44(7):578-82. doi: 10.1016/j.exphem.2016.04.008. Epub 2016 Apr 23. Exp Hematol. 2016. PMID: 27118044 Review.
Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia-a phase 3 study.
Braess J, Amler S, Kreuzer KA, Spiekermann K, Lindemann HW, Lengfelder E, Graeven U, Staib P, Ludwig WD, Biersack H, Ko YD, Uppenkamp MJ, De Wit M, Korsten S, Peceny R, Gaska T, Schiel X, Behringer DM, Kiehl MG, Zinngrebe B, Meckenstock G, Roemer E, Medgenberg D, Spaeth-Schwalbe E, Massenkeil G, Hindahl H, Schwerdtfeger R, Trenn G, Sauerland C, Koch R, Lablans M, Faldum A, Görlich D, Bohlander SK, Schneider S, Dufour A, Buske C, Fiegl M, Subklewe M, Braess B, Unterhalt M, Baumgartner A, Wörmann B, Beelen D, Hiddemann W; AML-CG. Braess J, et al. Among authors: fiegl m. Leukemia. 2018 Dec;32(12):2558-2571. doi: 10.1038/s41375-018-0268-9. Epub 2018 Oct 1. Leukemia. 2018. PMID: 30275528 Free PMC article. Clinical Trial.
[Small cell lung cancer].
Hoschek S, Hoschek-Risslegger U, Fiegl M, Zabernigg A, Pall G, Auberger T, Gunsilius E, Schmid T, Jamnig H, Hilbe W; Tiroler Arbeitskreis für Onkologie TAKO. Hoschek S, et al. Among authors: fiegl m. Wien Klin Wochenschr. 2007;119(23-24):697-710. doi: 10.1007/s00508-007-0913-1. Wien Klin Wochenschr. 2007. PMID: 18157602 Review. German.
Patients with spontaneous remission of high-risk MDS and AML show persistent preleukemic clonal hematopoiesis.
Grunwald VV, Hentrich M, Schiel X, Dufour A, Schneider S, Neusser M, Subklewe M, Fiegl M, Hiddemann W, Spiekermann K, Rothenberg-Thurley M, Metzeler KH. Grunwald VV, et al. Among authors: fiegl m. Blood Adv. 2019 Sep 24;3(18):2696-2699. doi: 10.1182/bloodadvances.2019000265. Blood Adv. 2019. PMID: 31515231 Free PMC article.
Prognostic and predictive value of cell cycle deregulation in non-small-cell lung cancer.
Sterlacci W, Fiegl M, Tzankov A. Sterlacci W, et al. Among authors: fiegl m. Pathobiology. 2012;79(4):175-94. doi: 10.1159/000336462. Epub 2012 Mar 21. Pathobiology. 2012. PMID: 22441109 Free article. Review.
163 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback